SequelSEC

Disc Medicine, Inc. IRON

Pharmaceutical Preparations · CIK 0001816736 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2025-12-31
Operating income
-$236.02M
Fiscal year ended 2025-12-31
Free cash flow
-$181.33M
Fiscal year ended 2025-12-31

Disc Medicine, Inc. (IRON) reported net income of -$212.18M for the fiscal year ended 2025-12-31. This page shows 6 annual periods of income statement, balance sheet and cash flow figures normalized from Disc Medicine, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Disc Medicine, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
RevenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$236.02M-$129.72M-$91.12M-$47.48M-$30.93M-$34.04M
Net income-$212.18M-$109.36M-$76.43M-$46.83M-$35.97M-$40.84M
Research & development$170.64M$96.67M$69.26M$33.44M$25.17M$28.17M
Weighted-average diluted sharesshares 35.30Mshares 27.61Mshares 22.32Mshares 1.04MUnavailableUnavailable
Pretax income-$211.82M-$109.00M-$76.33M-$46.83MUnavailableUnavailable
Income tax expense$361.00K$355.00K$99.00K$0UnavailableUnavailable
Diluted EPS$-6.01$-3.96$-3.42$-45.05$-40.95Unavailable
Selling, general & administrative$65.38M$33.05M$21.86MUnavailableUnavailableUnavailable
General & administrativeUnavailableUnavailable$21.86M$14.04M$5.76M$5.87M
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Disc Medicine, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Cash & equivalents$91.14M$192.43M$360.38M$194.61M$88.04M$4.50M
Total assets$806.88M$496.77M$368.00M$200.20M$92.41M$8.32M
Current assets$803.90M$493.62M$365.66M$198.49M$90.48M$5.06M
Total liabilities$67.05M$53.19M$22.88M$23.60M$14.76M$30.18M
Current liabilities$36.64M$23.32M$21.44M$22.58M$13.42M$24.88M
Total equity incl. NCI$739.83M$443.59M$345.12M$176.60M-$64.20M-$28.81M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailable$112.27M
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt$29.16M$28.32M$0UnavailableUnavailable$14.00M
Accounts payable$9.02M$7.95M$12.63M$16.16M$2.56M$2.38M

Cash flow

Disc Medicine, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Operating cash flow-$180.39M-$93.93M-$73.46M-$42.25M-$27.53M-$32.71M
Capital expenditures$933.00K$505.00K$89.00K$151.00K$68.00K$22.00K
Investing cash flow-$394.30M-$292.33M-$89.00K-$151.00K-$68.00K-$22.00K
Financing cash flow$473.41M$218.31M$239.38M$148.98M$89.93M$34.25M
Net change in cash-$101.28M-$167.94M$165.83M$106.58M$62.33M$1.52M
Stock-based compensation$34.34M$16.82M$5.53M$2.09M$507.00K$983.00K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$281.00K$156.00K$100.00K$89.00K$32.00KUnavailable

Derived

Disc Medicine, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Free cash flow-$181.33M-$94.43M-$73.55M-$42.40M-$27.60M-$32.73M
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio21.94x21.17x17.06x8.79x6.74x0.20x
Revenue YoY growthUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equity0.04xUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open IRON in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-07-30View SEC filing
10-Q · Filed 2026-05-05View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-07View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Reconciliation checks needing review

2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2021-12-31

Difference 141856000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.

balance equationreview2020-12-31

Difference 105320740 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.